UPDATE 1-S&amp;P delivers third blow to Merck &#39;AAA&#39; ratings
28766
Merck &amp; Co. (MRK.N: Quote, Profile, Research) saw its ratings slashed by a third credit ratings agency on Tuesday as Standard &amp; Poor&#39;s delivered the final blow
90989
The medical device maker reported a third-quarter loss of $272 million on charges related to acquisitions and asset sales, as the companyâs top-selling stent continued to slump.
220779
Stocks fell for a third straight day on Thursday, with the S&P 500 and the Nasdaq sliding 1 percent, after a sharp jump in Treasury debt yields stirred concerns about inflation and higher interest rates.
45408
What a mess. Weeks after Merck &amp; Co. (MRK ) yanked its blockbuster painkiller Vioxx off the market, the furor is still raging.
199304
WHITEHOUSE STATION, NJ - Merck and Co. shares fell more than 10 per cent in trading on the NYSE on Monday amid reports that company documents showed the pharmaceutical firm knew for years about health issues related to its arthritis drug Vioxx.
129945
A GLOBAL drugs recall caused a $US26.5 billion ($A36.5 billion) wipeout for US giant Merck &amp; Co yesterday. Merck&#39;s loss was the equivalent of the entire Commonwealth Bank, which has a similar market capitalisation
642614
The last vestige of Merck&#39;s (MRK:NYSE - news - research) once-pristine credit was dispatched with Tuesday when Standard &amp; Poor&#39;s cut its long-term debt rating by three notches to double-A-minus from triple-A.
769773
TRENTON, N.J. -- Shares of drug maker Merck &amp; Co. dropped 2.5 percent in heavy trading yesterday, a day after medical journal reports offered fresh ammunition to patients suing over its withdrawn painkiller Vioxx.
168349
Shares of Merck and Co. plunged almost nine per cent Monday after a media report said that documents show the pharmaceutical giant hid or denied evidence for years that its blockbuster
196745
Wall Street stock indexes closed out a dismal third quarter mixed Thursday after Merck &amp; Co. stated it would remove its best-selling Vioxx arthritis drug from the market.
570243
Merck & Co. MRK.N on Thursday said  its third-quarter profit fell, hurt by big charges for the  recall of the company's Vioxx arthritis drug in late September  after it was linked to heart attacks and strokes.
686772
Merck &amp; Co. shares fell as much as 7 percent to their lowest level in more than eight years after the Wall Street Journal said the drugmaker tried for years to stop safety concerns from hurting sales of its Vioxx painkiller.
673213
BOSTON (CBS.MW) -- Merck &amp; Co. shares fell more than 10 percent Monday on a news report that the company may have known for years that Vioxx, the pain reliever it recently withdrew from the market, could cause cardiac problems in some patients.
93237
Merck & Co. Inc. MRK.N, reeling from  the recent withdrawal of its Vioxx arthritis drug, on Wednesday  said 2005 earnings will decline to levels below Wall Street  expectations, the third straight year of lower results.
446587
Merck & Company said that third-quarter earnings plunged 29 percent after the recall of its Vioxx painkiller.
311418
Investors in pharmaceuticals were dealt  a triple whammy on Friday as Pfizer Inc, AstraZeneca Plc and  Eli Lilly and Co all shocked the market with bad news about key  products.
577018
THE REGION New York Times Co.'s debt rating was cut one level to BBB, the second-lowest investment grade, by Standard &amp; Poor's, which cited falling advertising sales and the broader newspaper industry decline. The short-term corporate credit and commercial paper ratings for the New York publisher were also lowered, S&amp;P said. Total advertising revenue fell 8.5 percent to $157.3 million ...